Scott, Gregory D;
Arnold, Moriah R;
Beach, Thomas G;
Gibbons, Christopher H;
Kanthasamy, Anumantha G;
Lebovitz, Russell M;
Lemstra, Afina W;
... Irwin, David J; + view all
(2022)
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium.
Frontiers in Neurology
, 12
, Article 805135. 10.3389/fneur.2021.805135.
Preview |
Text
fneur-12-805135.pdf - Published Version Download (298kB) | Preview |
Abstract
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and Parkinson's disease dementia (PDD). The meeting featured eight internationally known scientists from Europe and the United States and attracted over 200 scientists and physicians from academic centers, the National Institutes of Health, and the pharmaceutical industry. Methods for confirming and quantifying the presence of Lewy body and Alzheimer's pathology and novel biomarkers were discussed.
| Type: | Article |
|---|---|
| Title: | Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium |
| Location: | Switzerland |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.3389/fneur.2021.805135 |
| Publisher version: | https://doi.org/10.3389/fneur.2021.805135 |
| Language: | English |
| Additional information: | This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third-party material in this article are included in the Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| Keywords: | LBDA biomarker symposium, Lewy body dementia, alpha-synuclein, amyloid, cerebrospinal fluid, seeded aggregation assays, skin biopsy, tau |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10144184 |
Archive Staff Only
 |
View Item |
